Navigation Links
Berkery Noyes Represents Princeton Media Associates in Its Sale to HMP Communications/Alta
Date:4/29/2008

Sale provides liquidity to selling shareholders, opportunities for buyer to capitalize on valuable healthcare and medical communications franchise

NEW YORK, April 29 /PRNewswire/ -- Berkery Noyes announced today that the firm represented Princeton Media Associates in its sale to HMP Communications, a portfolio company of Alta Communications. The management team will continue to have an investment in the new combined entity. Terms of the transaction were not disclosed.

"This is an excellent combination with HMP Communications acquiring a seasoned management team with a winning healthcare and information franchise," said Tom O'Connor, the Berkery Noyes Managing Director who managed the transaction on behalf of Princeton Media Associates. "Princeton Media Associates is a world class franchise in an attractive growth segment of the ever expanding healthcare market," O'Connor added.

Berkery Noyes has been involved with many of the most notable transactions in the healthcare, pharmaceutical tools and services, and medical marketing sectors involving both strategic and financial buyers and sellers.

Berkery Noyes acted as Princeton Media Associates exclusive financial advisor and represented it in its negotiations with HMP Communications/Alta Communications.

About Berkery Noyes

Berkery Noyes is one of the pre-eminent merger and acquisition firms serving the information industry. Among the most recent transactions completed by Berkery Noyes are the sale of HCPro, Inc., a portfolio company of The Riverside Group to Halyard Capital, the divesture by The Thomson Corporation of Center Watch/NEIRB to Jobson Medical Information a portfolio company of The Wicks Group, HMP Communications, a portfolio company of BG Media, to Alta Communications in partnership with Paul Mackler and Ken Fisher, the sale of Complete Healthcare Communications to MediMedia a portfolio company of Vestar Capital Partners, the divesture by The Thomson Corporati
'/>"/>

SOURCE Berkery Noyes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Berkery Noyes Represented The Riverside Company on the Sale of HCPro Holdings, Inc. to Halyard Capital, LLC
2. Bush Budget Represents Double Whammy Hit on U.S. Seniors Medicare-Financed Nursing Facility Care
3. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
4. Princeton scientists break choleras lines of communication
5. First look: Princeton researchers peek into deepest recesses of human brain
6. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
7. AUDIO from Medialink and Radica: Staying Sharp with Games for Your Brain
8. AUDIO from Medialink and Kelloggs: Whats in Your Water?
9. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
10. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
11. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009).... 4 , ,What: Humana ( ht... health benefits provider, is introd...s.com ), a senior-friendly dance pad, ...ues., Dec. 8 at 1 p.m. The festive ...n to the public, will feature Dancetown, ...
(Date:12/4/2009)...PRNewswire-FirstCall/ -- MedClean Technologies, In...Company has entered into a preferred stock purchas...ware limited liability company, doing business as... to the Purchase Agreement, MedClean will receive ...agreed to sell up to 750 shares of its Series C Pr...
(Date:12/4/2009)...Newswire/ -- PLUS Diagnostics announced today th...y services with the launch of a national hematolog... company,s expansion from a regional laboratory to...ering diagnostic services across a full range of s... now hematology/oncology. ,, PLUS Diagnostics ...
(Date:12/4/2009)...RNewswire-FirstCall/ -- PD-Rx Pharmaceuticals, Inc...5,012,334 for the first quarter ended September 30...ear. Operating income and net income for the quar...a 70% decrease over the same period last year. ,... sector sales. This trend is expected to continue...
(Date:12/4/2009)...swire/ -- The National Cancer Institute has awarde...Hutchinson Cancer Research Center to become the na...vice Contact Center. ,, The move will create 60...ng the size of its current CIS workforce - once th...is scheduled for March 15, 2010. The Seattle CIS c...
Breaking Medicine News(10 mins):Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3Health News:PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings 2Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2
... Madhya Pradesh may raise the retirement age of me... doctors posted in interior areas// in order to pr...etter health and medical services to people is a p...ce will also be provided to them," Chief Minister ...
... Dubai: With a motive of enabling women the best p...s about to commence a free breast cancer screening... The tests will enable all women in the emirate, U...ter treatment outcomes. Dr Hajer Al Hosani,...
... AMA President, Dr Mukesh Haikerwal, said today th...rocesses for assessing the skills// and experience... confidence in the quality of medicine in Australi... and fair to ensure the community gets expert medi...
... American scientists have identified a single prot... the development of diabetes//. Researchers at...calcineurin, is vital to the proper functioning of...0 genes that had already been linked to diabetes. ...
... According to a study conducted at the University ...evelopment of chronic pain following breast cancer...ve surgery, and severe post-operative pain. ...ths, near the breast, next to armpit and in the up...
... A team of scientists from Bristol University has ...e energy levels in living heart cells that will ai...rt attack. The scientists expect this techni... Chemistry. Dr Elinor Griffiths and her team...
Other Medicine News:Health News:Consistent National Standards For Assessment Of Overseas Trained Doctors A Priority 2Health News:Post-Operative Pain in Breast Cancer Surgery 2Health News:A glowing energy measure for heart cells 2
(Date:12/3/2009)...c. 3 Radiology imaging leader MEDR...ration capabilities at the November 2009 Radiology...t.PACS(TM) product, enabling the first radiology ...t release in the company,s newly branded Certegra...://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009).... 3 Wound Management...rapidly growing provider of specialty medical prod... Industry Representative Association (HIRA) to ser...ing representative to market the company,s core Ce...IRA will market and sell Wound Management Technolo...
(Date:12/3/2009)...re-FirstCall/ -- Cardium Therapeutics (NYSE Amex: ...diary, Tissue Repair Company, submitted a 510(k) p...d Drug Administration (FDA) seeking marketing clea...sed on positive data from the Company,s recently c...submission with the FDA covers Excellagen XL(TM) ...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 1Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 2Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 1SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 2SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 4SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 5SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 6SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 7SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 8SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 9SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 10Combo Treatment May Ease Depression After Stroke 53891 1Combo Treatment May Ease Depression After Stroke 53891 2
TME 228 TS
TME 63 TC
TME 66 S
TME 64 S-3
Medicine Products: